Early-Stage Optimization of Lentiviral Vector Projects at VIVEbiotech
Our team supports partners with tailored strategies for safe, efficient, and scalable manufacturing.
At VIVEbiotech, we are dedicated to helping our partners advance their lentiviral vector projects with specialized technical support from the very beginning. Our team conducts an early integrated analysis of each vector candidate to ensure it meets regulatory and safety standards and is prepared for robust pharmaceutical development. From the initial stages, we recommend modifications to meet regulatory compliance and implement a range of optimization strategies to improve lentiviral vector yields, aligned with our customers’ goals.
All early-stage work takes place at lab scale, allowing us to generate highly valuable data quickly. This approach facilitates a smooth transition into bioreactor manufacturing while contributing to processes that are more cost-efficient, scalable, and robust.
If you want to learn more about how VIVEbiotech can support your lentiviral vector projects, please contact us — we’re ready to help you succeed.
📹 Watch the full video on YouTube or LinkedIn to see Miren Zuazo explain our early-stage project transfer strategies in detail.